Haibo Liu

Dr. Haibo Liu


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 2020 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
YGYu Gao
Yu Gao
FWFengxue Wang
Fengxue Wang
YSYanjun Song
Yanjun Song
HLHaibo Liu
Haibo Liu
Berberine has significant antibacterial and antipyretic effects and is a commonly used drug for treating infectious diarrhoea. The current research data show that the pharmacological effects of berberine are numerous and complex, and researchers have been enthusiastic about this field. To allow researchers to quickly understand the field and to provide references for the direction of research, using bibliometrics, we analysed 1426 articles, dating from 1985 to 2018, in the field of berberine pharmacology. The research articles we found came from 69 countries/regions, 1381 institutions, 5675 authors, and 325 journals; they contained 3794 key words; they were written in 7 languages; and they were of 2 article types. This study summarizes and discusses the evolution of the historical themes of berberine pharmacology as well as the status quo and the future development directions from a holistic perspective.

1 December 2020 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
XYXiao-Jing Yan
Xiao-Jing Yan
ZWZhi-Gang Wang
Zhi-Gang Wang
YWYang Wang
Yang Wang
YHYu-Ying Huang
Yu-Ying Huang
HLHaibo Liu
Haibo Liu
JXJing-Yuan Xu
Jing-Yuan Xu

1 December 2020 in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
Verified
Journal Article
Closed access
YHYu-Ying Huang
Yu-Ying Huang
FWFeng-Xue Wang
Feng-Xue Wang
SMSi-Yu Mu
Si-Yu Mu
XSXian Sun
Xian Sun
QLQing-Zhong Li
Qing-Zhong Li
HLHaibo Liu
Haibo Liu

17 December 2015 in Chinese Medicine
Verified
Journal Article
Open access
PDF file
QLQifang Lei
Qifang Lei
HLHaibo Liu
Haibo Liu
YPYong Peng
Yong Peng
PXPeigen Xiao
Peigen Xiao
Some isoquinoline alkaloids from Macleaya cordata (Willd). R. Br. (Bo Luo Hui) exhibited antibacterial, antiparasitic, antitumor, and analgesic effects. The targets of these isoquinoline alkaloids are undefined. This study aims to investigate the compound–target interaction network and potential pharmacological actions of isoquinoline alkaloids of M. cordata by reverse pharmacophore database screening. The targets of 26 isoquinoline alkaloids identified from M. cordata were predicted by a pharmacophore-based target fishing approach. Discovery Studio 3.5 and two pharmacophore databases (PharmaDB and HypoDB) were employed for the target profiling. A compound–target interaction network of M. cordata was constructed and analyzed by Cytoscape 3.0. Thirteen of the 65 predicted targets identified by PharmaDB were confirmed as targets by HypoDB screening. The targets in the interaction network of M. cordata were involved in cancer (31 targets), microorganisms (12 targets), neurodegeneration (10 targets), inflammation and autoimmunity (8 targets), parasitosis (5 targets), injury (4 targets), and pain (3 targets). Dihydrochelerythrine (C6) was found to hit 23 fitting targets. Macrophage migration inhibitory factor (MIF) hits 15 alkaloids (C1–2, C11–16, C19–25) was the most promising target related to cancer. Through in silico target fishing, the anticancer, anti-inflammatory, and analgesic effects of M. cordata were the most significant among many possible activities. The possible anticancer effects were mainly contributed by the isoquinoline alkaloids as active components.

21 January 2024 in Phytomedicine
Verified
Journal Article
Closed access
ZHZiyu Hou
Ziyu Hou
LSLe Sun
Le Sun
ZJZheyu Jiang
Zheyu Jiang
TZTiexin Zeng
Tiexin Zeng
PWPeiling Wu
Peiling Wu
PXPeigen Xiao
Peigen Xiao

28 April 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YSYanjun Song
Yanjun Song
PMPei Ma
Pei Ma
YGYu Gao
Yu Gao
PXPeigen Xiao
Peigen Xiao
LXLijia Xu
Lijia Xu
HLHaibo Liu
Haibo Liu
Metformin, the first-line oral blood glucose-lowering agent to manage type 2 diabetes, has gained growing popularity on both clinical application and basic research since early 1980s. A thorough and systematic knowledge map of metformin is pertinent to evaluate the research frontier and determine knowledge gaps. To this end, 20, 526 publications were analyzed by bibliometrics and data visualization to demonstrate the current global research status, potential hotspots, and perspectives on future research directions. In addition, the metformin development along the historical line was illustrated over the last 40 years. In sum, this study provides a comprehensive analysis that delineates the evolution of the historical milestones of metformin development, and we discuss the future research directions based on objective data analysis from a wide spectrum of metformin research areas.